Halozyme
HALO
161 hedge funds and large institutions have $967M invested in Halozyme in 2016 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 66 increasing their positions, 40 reducing their positions, and 30 closing their positions.
397% more call options, than puts
Call options by funds: $20.8M | Put options by funds: $4.18M
65% more repeat investments, than reductions
Existing positions increased: 66 | Existing positions reduced: 40
3% less funds holding
Funds holding: 166 → 161 (-5)
10% less first-time investments, than exits
New positions opened: 27 | Existing positions closed: 30
43% less capital invested
Capital invested by funds: $1.71B → $967M (-$744M)
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
First Eagle Investment Management
New York
|
+$22.2M |
| 2 |
SCM
Snyder Capital Management
San Francisco,
California
|
+$15.8M |
| 3 |
JP Morgan Chase
New York
|
+$11.4M |
| 4 |
MP
MSD Partners
New York
|
+$8.66M |
| 5 |
VOYA Investment Management
Atlanta,
Georgia
|
+$5.81M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$36M |
| 2 |
Bank of New York Mellon
New York
|
-$12.2M |
| 3 |
LOAMS
Lombard Odier Asset Management (Switzerland)
Petit-Lancy,
Switzerland
|
-$8.32M |
| 4 |
Prudential Financial
Newark,
New Jersey
|
-$5.27M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$4.65M |
HALO Hedge Fund Activity: Q1 2016 in Review
161 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Halozyme (HALO) for Q1 2016, worth a combined $967M — down 43% from $1.71B a quarter earlier.
Sellers outnumbered buyers: 30 funds closed out of HALO and 27 opened new positions — a net loss of 3 holders — while 40 trimmed existing stakes and 66 added.
The largest buyer was First Eagle Investment Management, adding an estimated $22.2M. The largest seller was Sectoral Asset Management, exiting entirely with an estimated $36M sold.
- 161 institutional investors held Halozyme (HALO) as of Q1 2016, down from 166 in Q4 2015.
- Funds reported $967M of Halozyme stock for Q1 2016, down 43% quarter-over-quarter.
- 27 funds opened new Halozyme positions in Q1 2016 and 30 closed out, a net change of -3 holders.
- The largest Halozyme buyer in Q1 2016 was First Eagle Investment Management, an estimated $22.2M added.
- The largest Halozyme seller in Q1 2016 was Sectoral Asset Management, an estimated $36M sold.
Based on aggregated 13F filings for Q1 2016.